SES - Delayed Quote SGD

Clearbridge Health Limited (1H3.SI)

0.0030
0.0000
(0.00%)
At close: May 9 at 1:48:57 PM GMT+8
Loading Chart for 1H3.SI
  • Previous Close 0.0030
  • Open 0.0030
  • Bid 0.0020 x --
  • Ask 0.0030 x --
  • Day's Range 0.0030 - 0.0030
  • 52 Week Range 0.0020 - 0.0140
  • Volume 139,000
  • Avg. Volume 2,812,800
  • Market Cap (intraday) 6.506M
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services. It also offers aesthetics, and dental and orthodontics services, as well as consultancy services for healthcare organization; and wholesales medicinal and pharmaceutical products. Clearbridge Health Limited was incorporated in 2010 and is based in Singapore.

www.clearbridgehealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1H3.SI

View More

Performance Overview: 1H3.SI

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .

YTD Return

1H3.SI
25.00%
STI Index (^STI)
2.34%

1-Year Return

1H3.SI
70.00%
STI Index (^STI)
18.68%

3-Year Return

1H3.SI
96.25%
STI Index (^STI)
18.35%

5-Year Return

1H3.SI
98.46%
STI Index (^STI)
49.55%

Compare To: 1H3.SI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1H3.SI

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    6.51M

  • Enterprise Value

    9.58M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.21

  • Price/Book (mrq)

    0.71

  • Enterprise Value/Revenue

    0.97

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -36.43%

  • Return on Assets (ttm)

    -10.99%

  • Return on Equity (ttm)

    -34.63%

  • Revenue (ttm)

    9.9M

  • Net Income Avi to Common (ttm)

    -3.72M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.88M

  • Total Debt/Equity (mrq)

    56.44%

  • Levered Free Cash Flow (ttm)

    -393.12k

Research Analysis: 1H3.SI

View More

Company Insights: 1H3.SI

Research Reports: 1H3.SI

View More

People Also Watch